🇯🇵·Jun 1Industry
近視の進行抑制を目的とする点眼剤STN1012700（Ryjusea 0.25mg/mL点眼液）についてアジア事業地域で初めてとなる販売承認をフィリピンで取得
Publisher
S
Santen Pharmaceutical News
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Santen Pharmaceutical News
- Region
- Japan
- Scope
- Industry
- Published
- June 1, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on santen.com
Leave the platform to read the original full article on the publisher site.
Source: Santen Pharmaceutical News
Scope: Industry
Related coverage
More related coverage
Certara/3h ago
Mechanistic Surface pH Modelling Improves PBPK Prediction of a Weakly Acidic Drug: Case Study of Bempedoic Acid
Nippon Shinyaku News/3h ago
EXG-7001のオプション契約締結のお知らせ
Certara/6h ago
Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework
Certara/6h ago